ArticleFrontiers in immunology2025

SLC16A3 drives lung adenocarcinoma progression and gefitinib resistance through coordinated regulation of ferroptosis and lactate metabolism.

Wenhan Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.